Learn more

NEURO3D

Overview
  • Total Patents
    31
About

NEURO3D has a total of 31 patent applications. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are YM BIOSCIENCES AUSTRALIA PTY, NEURAXON INC and MIIKANA THERAPEUTICS INC.

Patent filings per year

Chart showing NEURO3Ds patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Mondadori Cesare 17
#2 Biondi Stefano 14
#3 Wagner Patrick 12
#4 Abarghaz Mustapha 11
#5 Bourguignon Jean-Jacques 9
#6 Duranton Jerome 8
#7 Lugnier Claire 8
#8 Macher Jean-Paul 8
#9 Lagouge Yan 8
#10 Raboisson Pierre 8

Latest patents

Publication Filing date Title
EP1749824A1 Benzodiazepine derivatives, their preparation and the therapeutic use thereof
EP1695973A1 Ocaperidone salt and pharmaceutical compositions containing the same
EP1690540A1 Composition comprising ocaperidone
EP1548011A1 Benzo[1,4]diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof
EP1500391A1 Therapeutic use of bicycloheptane derivatives
EP1470818A1 Use of piperazine phenothiazine derivatives in the manufacture of a medicament with neuroprotector and/or neurotrophic effects on cns and/or pns
FR2846653A1 Inhibitors of cyclic nucleotide phosphodiesterases, preparation and uses
NZ529582A Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
FR2827599A1 Treating central nervous system disorders, e.g. anxiety, depression, schizophrenia or pain, using new or known 2-substituted quinoline or quinoxaline derivatives having xanthenuric acid modulating action
FR2824065A1 Compounds inhibitors of cyclic nucleotide phosphodiesterases, preparation and uses